Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05307796 · ClinicalTrials.gov registry record · NA
Incorporating Strategy Training Into Naming Treatment in Aphasia
A NA study, sponsored by MGH Institute of Health Professions.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT05307796 is a NA study that has completed, run by MGH Institute of Health Professions. The registered enrollment target is 10 participants.
The verdict
NCT05307796, a NA study, has completed, sponsored by MGH Institute of Health Professions.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
This study incorporates metacognitive strategy training into semantic feature analysis treatment. Semantic feature analysis treatment has a strong evidence base and capacity to improve word retrieval by encouraging circumlocution. Circumlocution facilitates self-cued naming and assists listener comprehension when naming fails. However, semantic feature analysis treatment does not include direct techniques to teach patients with aphasia to generalize the use of semantic feature analysis treatment's circumlocution procedure. Therefore, this study proposes that combining semantic feature analysis treatment and metacognitive strategy training will stimulate the semantic system and increase patients with aphasias' use of circumlocution across divergent contexts. This study aims to measure the treatment's effect on naming accuracy for trained and untrained items. The study also aim to measure the treatment's effect on people with aphasias' knowledge of the strategy components and changes in verbalizations during retrieval attempts. The central hypothesis is that strategy training will increase patients with aphasias' explicit knowledge about circumlocution and enable them to use it to (1) self-facilitate naming, and (2) produce more informative connected speech.
Interventions
- BEHAVIORAL Strategy training
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2021-08-30 |
| Est. Completion | 2022-05-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05307796
The ClinicalTrials.gov registry entry for NCT05307796 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is MGH Institute of Health Professions, which has 16 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Strategy training is the first listed.
NCT05307796 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05307796 about?
NCT05307796 is a clinical study titled "Incorporating Strategy Training Into Naming Treatment in Aphasia". This study incorporates metacognitive strategy training into semantic feature analysis treatment. Semantic feature analysis treatment has a strong evidence base and capacity to improve word retrieval by encouraging circumlocution. Circumlocution facilitates self-cued naming and assists listener comp...
What is the current status of trial NCT05307796?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2021-08-30. Estimated completion is 2022-05-11.
What interventions are being tested in trial NCT05307796?
The interventions under investigation include: Strategy training (BEHAVIORAL).
Who is sponsoring clinical trial NCT05307796?
This trial is sponsored by MGH Institute of Health Professions, which has 16 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.